{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:19:20Z","timestamp":1784222360618,"version":"3.55.0"},"reference-count":312,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001673","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007353","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neurot.2025.e00584","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T20:35:21Z","timestamp":1743971721000},"page":"e00584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Role of cystathionine-\u03b2-synthase and hydrogen sulfide in down syndrome"],"prefix":"10.1016","volume":"22","author":[{"given":"Csaba","family":"Szabo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11-12","key":"10.1016\/j.neurot.2025.e00584_bib1","first-page":"256","article-title":"Le mongolisme, maladie chromosomique","volume":"143","author":"Lejeune","year":"1959","journal-title":"Bull Acad Natl Med (Paris)"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00584_bib2","first-page":"12","article-title":"R\u00e9flexions sur la d\u00e9bilit\u00e9 de l'intelligence des enfants trisomiques 21","volume":"3","author":"Lejeune","year":"1975","journal-title":"Pont Acad Sci"},{"key":"10.1016\/j.neurot.2025.e00584_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bcp.2017.09.010","article-title":"A timeline of hydrogen sulfide (H2S) research: from environmental toxin to biological mediator","volume":"149","author":"Szabo","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib4","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1523\/JNEUROSCI.16-03-01066.1996","article-title":"The possible role of hydrogen sulfide as an endogenous neuromodulator","volume":"16","author":"Abe","year":"1996","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00584_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/ars.2017.7076","article-title":"Hydrogen sulfide and polysulfide signaling","volume":"27","author":"Kimura","year":"2017","journal-title":"Antioxidants Redox Signal"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00584_bib6","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3390\/biom11060896","article-title":"Hydrogen sulfide (H2S) and polysulfide (H2Sn) signaling: the first 25 years","volume":"11","author":"Kimura","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/10408448409029321","article-title":"A critical review of the literature on hydrogen sulfide toxicity","volume":"13","author":"Beauchamp","year":"1984","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.neurot.2025.e00584_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.pa.32.040192.000545","article-title":"Toxicology of hydrogen sulfide","volume":"32","author":"Reiffenstein","year":"1992","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1054\/mehy.2001.1377","article-title":"Mental retardation in Down syndrome: a hydrogen sulfide hypothesis","volume":"57","author":"Kamoun","year":"2001","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.neurot.2025.e00584_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2019.109289","article-title":"Mental retardation in Down syndrome: two ways to treat","volume":"131","author":"Kamoun","year":"2019","journal-title":"Med Hypotheses"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00584_bib11","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/clinchem\/47.8.1500","article-title":"Urinary sulfur compounds in Down syndrome","volume":"47","author":"Belardinelli","year":"2001","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajmg.a.10847","article-title":"Endogenous hydrogen sulfide overproduction in Down syndrome","volume":"116A","author":"Kamoun","year":"2003","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib13","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.bbrc.2005.10.118","article-title":"Cystathionine beta-synthase is enriched in the brains of Down's patients","volume":"338","author":"Ichinohe","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00584_bib14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1089\/ars.2013.5309","article-title":"Production and physiological effects of hydrogen sulfide","volume":"20","author":"Kimura","year":"2014","journal-title":"Antioxidants Redox Signal"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00584_bib15","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00018-016-2406-8","article-title":"H2S biosynthesis and catabolism: new insights from molecular studies","volume":"74","author":"Rose","year":"2017","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib16","doi-asserted-by":"crossref","DOI":"10.1080\/13510002.2024.2437338","article-title":"Emerging roles of hydrogen sulfide-metabolizing enzymes in cancer","volume":"29","author":"Dawoud","year":"2024","journal-title":"Redox Rep"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1152\/physrev.00028.2021","article-title":"Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organs","volume":"103","author":"Cirino","year":"2023","journal-title":"Physiol Rev"},{"issue":"38","key":"10.1016\/j.neurot.2025.e00584_bib18","doi-asserted-by":"crossref","first-page":"18769","DOI":"10.1073\/pnas.1911895116","article-title":"Overproduction of H2S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down syndrome","volume":"116","author":"Panagaki","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00584_bib19","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/hmg\/ddy447","article-title":"Cbs overdosage is necessary and sufficient to induce cognitive phenotypes in mouse models of Down syndrome and interacts genetically with Dyrk1a","volume":"28","author":"Marechal","year":"2019","journal-title":"Hum Mol Genet"},{"issue":"15","key":"10.1016\/j.neurot.2025.e00584_bib20","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1111\/febs.15214","article-title":"The re-emerging pathophysiological role of the cystathionine-beta-synthase-hydrogen sulfide system in Down syndrome","volume":"287","author":"Szabo","year":"2020","journal-title":"FEBS J"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3390\/biom10040653","article-title":"Role of 3-mercaptopyruvate sulfurtransferase in the regulation of proliferation and cellular bioenergetics in human Down syndrome fibroblasts","volume":"10","author":"Panagaki","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.neurot.2025.e00584_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mito.2020.12.017","article-title":"Meta-analysis of gene expression patterns in Down syndrome highlights significant alterations in mitochondrial and bioenergetic pathways","volume":"57","author":"Pecze","year":"2021","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s10020-020-00225-8","article-title":"Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome","volume":"26","author":"Pecze","year":"2020","journal-title":"Mol Med"},{"key":"10.1016\/j.neurot.2025.e00584_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102233","article-title":"Overproduction of hydrogen sulfide, generated by cystathionine \u03b2-synthase, disrupts brain wave patterns and contributes to neurobehavioral dysfunction in a rat model of Down syndrome","volume":"51","author":"Panagaki","year":"2022","journal-title":"Redox Biol"},{"key":"10.1016\/j.neurot.2025.e00584_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102416","article-title":"Role of the cystathionine \u03b2-synthase\/H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in Down syndrome","volume":"55","author":"Panagaki","year":"2022","journal-title":"Redox Biol"},{"key":"10.1016\/j.neurot.2025.e00584_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.niox.2022.07.007","article-title":"Epigallocatechin gallate is a potent inhibitor of cystathionine beta-synthase: structure-activity relationship and mechanism of action","volume":"128","author":"Zuhra","year":"2022","journal-title":"Nitric Oxide"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00584_bib27","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1007\/s11357-024-01146-8","article-title":"Neurobehavioral dysfunction in a mouse model of Down syndrome: upregulation of cystathionine \u03b2-synthase, H2S overproduction, altered protein persulfidation, synaptic dysfunction and endoplasmic reticulum stress","volume":"46","author":"Panagaki","year":"2024","journal-title":"Geroscience"},{"key":"10.1016\/j.neurot.2025.e00584_bib28","article-title":"Oxidation of hydrogen sulfide to polysulfide and thiosulfate by a carbon nanozyme: therapeutic implications with an emphasis on Down syndrome","volume":"5","author":"Derry","year":"2023","journal-title":"Adv Mater"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00584_bib29","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3390\/antiox13111361","article-title":"SOD1 is an integral yet insufficient oxidizer of hydrogen sulfide in trisomy 21 B lymphocytes and can be augmented by a pleiotropic carbon nanozyme","volume":"13","author":"Mouli","year":"2024","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s11010-023-04761-9","article-title":"The role of the mitochondrial trans-sulfuration in cerebro-cardio renal dysfunction during trisomy Down syndrome","volume":"479","author":"Pushpakumar","year":"2024","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00584_bib31","doi-asserted-by":"crossref","first-page":"R1479","DOI":"10.1152\/ajpregu.90566.2008","article-title":"Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values","volume":"295","author":"Furne","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00584_bib32","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.bbabio.2009.03.019","article-title":"Is hydrogen sulfide a circulating \"gasotransmitter\" in vertebrate blood?","volume":"1787","author":"Olson","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib33","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1476-5381.2010.00704.x","article-title":"A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood","volume":"160","author":"Wintner","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00584_bib34","doi-asserted-by":"crossref","first-page":"R630","DOI":"10.1152\/ajpregu.00218.2013","article-title":"H2S concentrations in the arterial blood during H2S administration in relation to its toxicity and effects on breathing","volume":"305","author":"Klingerman","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00584_bib35","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3390\/biom13071023","article-title":"Circulating levels of hydrogen sulfide (H2S) in patients with age-related diseases: a systematic review and meta-analysis","volume":"13","author":"Piragine","year":"2023","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejmhg.2013.05.003","article-title":"Assessment of immune function in Down syndrome patients","volume":"14","author":"Abdel-Salam","year":"2013","journal-title":"Egyptian J Med Hum Genet"},{"key":"10.1016\/j.neurot.2025.e00584_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.117780","article-title":"First clinical evidence that trimethylsulfonium can serve as a biomarker for the production of the signaling molecule hydrogen sulfide","volume":"554","author":"Antonaros","year":"2024","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.neurot.2025.e00584_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123198","article-title":"Rapid determination of hydrogen sulfide-related metabolites in human urine by UHPLC-ESI-MS\/MS with fluorinated ion-pairing reagents","volume":"1196","author":"Lajin","year":"2022","journal-title":"J Chromatogr, B: Anal Technol Biomed Life Sci"},{"issue":"43","key":"10.1016\/j.neurot.2025.e00584_bib39","doi-asserted-by":"crossref","first-page":"38622","DOI":"10.1021\/acsomega.2c04112","article-title":"Variability in background urinary concentrations of the hydrogen sulfide biomarker thiosulfate","volume":"7","author":"Lajin","year":"2022","journal-title":"ACS Omega"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00584_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167013","article-title":"The association between the urinary excretion of trimethylselenonium and trimethylsulfonium in humans","volume":"11","author":"Lajin","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2025.e00584_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2022.340583","article-title":"Trace determination of the hydrogen sulfide biomarker thiosulfate in human urine by HPLC coupled with element selective ICPMS\/MS detection","volume":"1237","author":"Lajin","year":"2023","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.neurot.2025.e00584_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2023.104162","article-title":"A time-course investigation of the human urinary excretion of the hydrogen sulfide biomarker trimethylsulfonium","volume":"100","author":"Lajin","year":"2023","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00584_bib43","first-page":"23","article-title":"Mouse trisomy 16 as an animal model of human trisomy 21: a new approach for studying the pathogenesis of Down syndrome","volume":"22","author":"Cox","year":"1983","journal-title":"Mead Johns Symp Perinat Dev Med"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00584_bib44","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1242\/dmm.029728","article-title":"Rodent models in Down syndrome research: impact and future opportunities","volume":"10","author":"Herault","year":"2017","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.neurot.2025.e00584_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/bs.pbr.2019.08.001","article-title":"Modeling Down syndrome in animals from the early stage to the 4.0 models and next","volume":"251","author":"Mu\u00f1iz Moreno","year":"2020","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.neurot.2025.e00584_bib46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/bs.pbr.2019.10.001","article-title":"Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome","volume":"251","author":"Rueda","year":"2020","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.neurot.2025.e00584_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/bs.pbr.2020.01.005","article-title":"Mapping behavioral landscapes in Down syndrome animal models","volume":"251","author":"Mart\u00ednez de Lagr\u00e1n","year":"2020","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.neurot.2025.e00584_bib48","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2010.09.107","article-title":"Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice","volume":"1366","author":"Yu","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.neurot.2025.e00584_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/164_2017_72","article-title":"Potential pharmacological chaperones for cystathionine beta-synthase-deficient homocystinuria","volume":"245","author":"Majtan","year":"2018","journal-title":"Handb Exp Pharmacol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00584_bib50","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/biom10050697","article-title":"Cystathionine-\u03b2-synthase: molecular regulation and pharmacological inhibition","volume":"10","author":"Zuhra","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0006-291X(85)91641-9","article-title":"Cystathionine beta synthase: gene dosage effect in trisomy 21","volume":"128","author":"Chadefaux","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib52","first-page":"1393","article-title":"Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin","volume":"94","author":"Taub","year":"1999","journal-title":"Blood"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00584_bib53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00726-002-0337-1","article-title":"Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II)","volume":"24","author":"Cheon","year":"2003","journal-title":"Amino Acids"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00584_bib54","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2005-6-13-r107","article-title":"Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart","volume":"6","author":"Mao","year":"2005","journal-title":"Genome Biol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib55","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1086\/520000","article-title":"Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes","volume":"81","author":"A\u00eft Yahya-Graison","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"3-4","key":"10.1016\/j.neurot.2025.e00584_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000112058","article-title":"Specific transcriptional changes in human fetuses with autosomal trisomies","volume":"119","author":"Altug-Teber","year":"2007","journal-title":"Cytogenet Genome Res"},{"key":"10.1016\/j.neurot.2025.e00584_bib57","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1471-2164-8-268","article-title":"Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy","volume":"8","author":"Conti","year":"2007","journal-title":"BMC Genom"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib58","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000118930","article-title":"Development and aging expression of cystathionine-beta synthase in the temporal lobe and cerebellum of Down syndrome patients","volume":"4","author":"Kanaumi","year":"2006","journal-title":"Neuroembryol Aging"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00584_bib59","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ygeno.2007.08.005","article-title":"Gene expression profiling in the adult Down syndrome brain","volume":"90","author":"Lockstone","year":"2007","journal-title":"Genomics"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00584_bib60","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.4049\/jimmunol.1003053","article-title":"Decreased AIRE expression and global thymic hypofunction in Down syndrome","volume":"187","author":"Lima","year":"2011","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00584_bib61","article-title":"Genome-wide expression analysis in Down syndrome: insight into immunodeficiency","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"issue":"43","key":"10.1016\/j.neurot.2025.e00584_bib62","doi-asserted-by":"crossref","first-page":"17573","DOI":"10.1073\/pnas.1211175109","article-title":"Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells","volume":"109","author":"Chou","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"10.1016\/j.neurot.2025.e00584_bib63","doi-asserted-by":"crossref","first-page":"9962","DOI":"10.1073\/pnas.1216575110","article-title":"Deficits in human trisomy 21 iPSCs and neurons","volume":"110","author":"Weick","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7496","key":"10.1016\/j.neurot.2025.e00584_bib64","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature13200","article-title":"Domains of genome-wide gene expression dysregulation in Down's syndrome","volume":"508","author":"Letourneau","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neurot.2025.e00584_bib65","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.16220","article-title":"Trisomy 21 consistently activates the interferon response","volume":"5","author":"Sullivan","year":"2016","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/cge.12731","article-title":"Aneuploidy: the impact of chromosome imbalance on nuclear organization and overall genome expression","volume":"90","author":"Herv\u00e9","year":"2016","journal-title":"Clin Genet"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib67","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41467-017-01422-6","article-title":"Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib68","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s40200-022-01087-z","article-title":"Differential expression of cystathionine beta synthase in adolescents with Down syndrome: impact on adiposity","volume":"21","author":"Meguid","year":"2022","journal-title":"J Diabetes Metab Disord"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00584_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111312","article-title":"Molecular convergence between Down syndrome and fragile X syndrome identified using human pluripotent stem cell models","volume":"40","author":"Susco","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurot.2025.e00584_bib70","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/mnfr.201200162","article-title":"Blood biomarkers of methylation in Down syndrome and metabolic simulations using a mathematical model","volume":"56","author":"Obeid","year":"2012","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.neurot.2025.e00584_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1006891","article-title":"One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: relation to chromosomal dosage","volume":"9","author":"Vione","year":"2022","journal-title":"Front Med"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00584_bib72","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0929-693X(97)88974-9","article-title":"Variation of amino acids in relation to age in Down syndrome subjects","volume":"4","author":"Mircher","year":"1997","journal-title":"Arch Pediatr"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib73","first-page":"8","article-title":"Amino acids and trisomy 21","volume":"35","author":"Lejeune","year":"1992","journal-title":"Ann Genet"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib74","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1086\/321262","article-title":"Homocysteine metabolism in children with Down syndrome: in vitro modulation","volume":"69","author":"Pogribna","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00584_bib75","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jnnp.2004.039875","article-title":"Homocysteine and related genetic polymorphisms in Down's syndrome IQ","volume":"76","author":"Gu\u00e9ant","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00584_bib76","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00702-007-0656-1","article-title":"Plasma amino acids and neopterin in healthy persons with Down's syndrome","volume":"114","author":"Coppus","year":"2007","journal-title":"J Neural Transm"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib77","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1038\/s41467-019-12739-9","article-title":"Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors","volume":"10","author":"Powers","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurot.2025.e00584_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102958","article-title":"A role for the cystathionine-\u03b2-synthase\/H2S axis in astrocyte dysfunction in the aging brain","volume":"68","author":"Dey","year":"2023","journal-title":"Redox Biol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib79","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood-2002-07-2337","article-title":"Transcriptional regulation of the cystathionine-beta-synthase gene in Down syndrome and non-Down syndrome megakaryocytic leukemia cell lines","volume":"101","author":"Ge","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.neurot.2025.e00584_bib80","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fgene.2018.00125","article-title":"Integrated quantitative transcriptome maps of human trisomy 21 tissues and cells","volume":"9","author":"Pelleri","year":"2018","journal-title":"Front Genet"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00584_bib81","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1007\/s12035-019-1585-3","article-title":"Transcriptome and proteome profiling of neural induced pluripotent stem cells from individuals with Down syndrome disclose dynamic dysregulations of key pathways and cellular functions","volume":"56","author":"Sobol","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib82","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40246-021-00325-4","article-title":"The transcriptome profile of human trisomy 21 blood cells","volume":"15","author":"Antonaros","year":"2021","journal-title":"Hum Genom"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00584_bib83","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.ajhg.2022.10.014","article-title":"Consequences of chromosome gain: a new view on trisomy syndromes","volume":"109","author":"Krivega","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib84","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10577-023-09732-w","article-title":"Consequences of gaining an extra chromosome","volume":"31","author":"Torres","year":"2023","journal-title":"Chromosome Res"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00584_bib85","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.18632\/oncotarget.7120","article-title":"Modular transcriptional repertoire and microRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants","volume":"7","author":"Moreira-Filho","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00584_bib86","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3390\/antiox11091823","article-title":"Sequential accumulation of 'driver' pathway mutations induces the upregulation of hydrogen-sulfide-producing enzymes in human colonic epithelial cell organoids","volume":"11","author":"Ascen\u00e7\u00e3o","year":"2022","journal-title":"Antioxidants"},{"issue":"Pt 2","key":"10.1016\/j.neurot.2025.e00584_bib87","article-title":"Increased hydrogen sulfide turnover serves a cytoprotective role during the development of replicative senescence","volume":"230","author":"Kieronska-Rudek","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.01.003","article-title":"Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome","volume":"91","author":"Contestabile","year":"2010","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neurot.2025.e00584_bib89","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fnbeh.2016.00120","article-title":"Editorial: intellectual disabilities in Down syndrome from birth and throughout life: assessment and treatment","volume":"10","author":"Potier","year":"2016","journal-title":"Front Behav Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67195-z","article-title":"Plasma metabolome and cognitive skills in Down syndrome","volume":"10","author":"Antonaros","year":"2020","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00584_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084031","article-title":"Defective mitochondrial function in vivo in skeletal muscle in adults with Down's syndrome: a 31P-MRS study","volume":"8","author":"Phillips","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib92","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.dhjo.2017.12.009","article-title":"Total energy expenditure and body composition of children with developmental disabilities","volume":"11","author":"Polfuss","year":"2018","journal-title":"Disabil Health J"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib93","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jir.12792","article-title":"Comparison of uniaxial and triaxial accelerometer outputs among individuals with and without Down syndrome","volume":"65","author":"Leung","year":"2021","journal-title":"J Intellect Disabil Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib94","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/jir.12995","article-title":"Resting energy expenditure in adolescents with Down syndrome: a comparison of commonly used predictive equations","volume":"67","author":"Helsel","year":"2023","journal-title":"J Intellect Disabil Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib95","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/s41598-018-20834-y","article-title":"Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolism","volume":"8","author":"Caracausi","year":"2018","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00584_bib96","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/dneu.22716","article-title":"Plasma metabolites related to cellular energy metabolism are altered in adults with Down syndrome and Alzheimer's disease","volume":"79","author":"Gross","year":"2019","journal-title":"Dev Neurobiol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00584_bib97","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3390\/antiox11061208","article-title":"Biochemical discrimination of the Down syndrome-related metabolic and oxidative\/nitrosative stress alterations from the physiologic age-related changes through the targeted metabolomic analysis of serum","volume":"11","author":"Lazzarino","year":"2022","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib98","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cmet.2012.12.005","article-title":"Adaptive downregulation of mitochondrial function in Down syndrome","volume":"17","author":"Helguera","year":"2013","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib99","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s10020-018-0004-y","article-title":"Mitochondrial dysfunction in Down syndrome: molecular mechanisms and therapeutic targets","volume":"24","author":"Izzo","year":"2018","journal-title":"Mol Med"},{"key":"10.1016\/j.neurot.2025.e00584_bib100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2017.08.014","article-title":"Mitochondria as pharmacological targets in Down syndrome","volume":"114","author":"Valenti","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.neurot.2025.e00584_bib101","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.freeradbiomed.2021.06.003","article-title":"Trisomy 21 results in modest impacts on mitochondrial function and central carbon metabolism","volume":"172","author":"Anderson","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.neurot.2025.e00584_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101871","article-title":"Down syndrome is an oxidative phosphorylation disorder","volume":"41","author":"Bayona-Bafaluy","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.neurot.2025.e00584_bib103","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mito.2022.05.007","article-title":"Triplication of HSA21 on alterations in structure and function of mitochondria","volume":"65","author":"Ganguly","year":"2022","journal-title":"Mitochondrion"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00584_bib104","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/biology10070609","article-title":"Human trisomic iPSCs from Down syndrome fibroblasts manifest mitochondrial alterations early during neuronal differentiation","volume":"10","author":"Mollo","year":"2021","journal-title":"Biology"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00584_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166388","article-title":"Abnormal mitochondria in Down syndrome iPSC-derived GABAergic interneurons and organoids","volume":"1868","author":"Xu","year":"2022","journal-title":"Biochim Biophys Acta, Mol Basis Dis"},{"key":"10.1016\/j.neurot.2025.e00584_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2022.12.003","article-title":"Mitochondrial dysfunction in Down syndrome: from pathology to therapy","volume":"511","author":"Tan","year":"2023","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00584_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236826","article-title":"Phenotype microarrays reveal metabolic dysregulations of neurospheres derived from embryonic Ts1Cje mouse model of Down syndrome","volume":"15","author":"Seth","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib108","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/brainsci12010083","article-title":"Evidence of energy metabolism alterations in cultured neonatal astrocytes derived from the Ts65Dn mouse model of Down syndrome","volume":"12","author":"Zampieri","year":"2022","journal-title":"Brain Sci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib109","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0292-20.2021","article-title":"Distinct basal metabolism in three mouse models of neurodevelopmental disorders","volume":"8","author":"Menzies","year":"2021","journal-title":"eNeuro"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/antiox11010062","article-title":"Impaired brain mitochondrial bioenergetics in the Ts65Dn mouse model of Down syndrome is restored by neonatal treatment with the polyphenol 7,8-dihydroxyflavone","volume":"11","author":"Valenti","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.neurot.2025.e00584_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101666","article-title":"Dysregulated systemic metabolism in a Down syndrome mouse model","volume":"68","author":"Sarver","year":"2023","journal-title":"Mol Metabol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00584_bib112","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0891-5849(03)00329-0","article-title":"Redox regulation of neuronal migration in a Down syndrome model","volume":"35","author":"Behar","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.neurot.2025.e00584_bib113","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1477-5956-7-31","article-title":"Transchromosomic cell model of Down syndrome shows aberrant migration, adhesion and proteome response to extracellular matrix","volume":"7","author":"Delom","year":"2009","journal-title":"Proteome Sci"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00584_bib114","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1002\/jnr.22131","article-title":"Proliferation deficits and gene expression dysregulation in Down's syndrome (Ts1Cje) neural progenitor cells cultured from neurospheres","volume":"87","author":"Moldrich","year":"2009","journal-title":"J Neurosci Res"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00584_bib115","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/labinvest.2012.117","article-title":"Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched 1 overexpression","volume":"92","author":"Fuchs","year":"2012","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib116","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbadis.2013.10.014","article-title":"Decreased cell proliferation and higher oxidative stress in fibroblasts from Down syndrome fetuses. Preliminary study","volume":"1842","author":"Gimeno","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00584_bib117","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/stem.1968","article-title":"Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic Down syndrome model accelerated neuronal ageing and neurodegeneration","volume":"33","author":"Murray","year":"2015","journal-title":"Stem Cell"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib118","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3233\/JAD-160278","article-title":"Metabolic and growth rate alterations in lymphoblastic cell lines discriminate between Down syndrome and Alzheimer's disease","volume":"55","author":"Coskun","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib119","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s42003-021-02242-7","article-title":"A human isogenic iPSC-derived cell line panel identifies major regulators of aberrant astrocyte proliferation in Down syndrome","volume":"4","author":"Kawatani","year":"2021","journal-title":"Commun Biol"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00584_bib120","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1111\/febs.16135","article-title":"The two faces of cyanide: an environmental toxin and a potential novel mammalian gasotransmitter","volume":"289","author":"Zuhra","year":"2022","journal-title":"FEBS J"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00584_bib121","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3390\/biomedicines9111741","article-title":"Energy metabolism and intracellular pH alteration in neural spheroids carrying Down syndrome","volume":"9","author":"Kashirina","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.neurot.2025.e00584_bib122","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1038\/ncomms4480","article-title":"Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway","volume":"5","author":"Yamamoto","year":"2014","journal-title":"Nat Commun"},{"issue":"15","key":"10.1016\/j.neurot.2025.e00584_bib123","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1523\/JNEUROSCI.5338-13.2014","article-title":"Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down's syndrome","volume":"34","author":"Kaur","year":"2014","journal-title":"J Neurosci"},{"issue":"Pt B","key":"10.1016\/j.neurot.2025.e00584_bib124","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.pnpbp.2017.09.014","article-title":"Glutamatergic synapses in neurodevelopmental disorders","volume":"84","author":"Moretto","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neurot.2025.e00584_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1171797","article-title":"Glutamatergic synaptic deficits in the prefrontal cortex of the Ts65Dn mouse model for Down syndrome","volume":"17","author":"Thomazeau","year":"2023","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neurot.2025.e00584_bib126","series-title":"Biochemistry, anaerobic glycolysis. StatPearls, treasure island (FL)","author":"Melkonian","year":"2022"},{"key":"10.1016\/j.neurot.2025.e00584_bib127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185085","article-title":"The Warburg effect as an adaptation of cancer cells to rapid fluctuations in energy demand","volume":"12","author":"Epstein","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00584_bib128","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1042\/BST20130070","article-title":"Sulfide inhibition of and metabolism by cytochrome c oxidase","volume":"41","author":"Nicholls","year":"2013","journal-title":"Biochem Soc Trans"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00584_bib129","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/bph.12369","article-title":"Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms","volume":"171","author":"Szabo","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0304-3940(91)90864-P","article-title":"Chronic exposure to low concentrations of hydrogen sulfide produces abnormal growth in developing cerebellar Purkinje cells","volume":"122","author":"Hannah","year":"1991","journal-title":"Neurosci Lett"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00584_bib131","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1139\/y92-215","article-title":"Low concentrations of hydrogen sulphide alter monoamine levels in the developing rat central nervous system","volume":"70","author":"Skrajny","year":"1992","journal-title":"Can J Physiol Pharmacol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00584_bib132","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1440-1681.1995.tb02024.x","article-title":"Alteration of the morphology and neurochemistry of the developing mammalian nervous system by hydrogen sulphide","volume":"22","author":"Roth","year":"1995","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00584_bib133","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/009841098158773","article-title":"Inhibition of respiratory and bioenergetic mechanisms by hydrogen sulfide in mammalian brain","volume":"54","author":"Nicholson","year":"1998","journal-title":"J Toxicol Environ Health"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib134","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/toxsci\/50.2.228","article-title":"Bioactivation of cyanide to cyanate in sulfur amino acid deficiency: relevance to neurological disease in humans subsisting on cassava","volume":"50","author":"Tor-Agbidye","year":"1999","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03033325","article-title":"Neurochemical and behavioural correlates in cassava-induced neurotoxicity in rats","volume":"2","author":"Mathangi","year":"2000","journal-title":"Neurotox Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib136","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0161-813X(01)00016-X","article-title":"Effects of repeated hydrogen sulphide (H2S) exposure on learning and memory in the adult rat","volume":"22","author":"Partlo","year":"2001","journal-title":"Neurotoxicology"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00584_bib137","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0278-6915(02)00151-5","article-title":"Neuropathologic study of long-term cyanide administration to goats","volume":"40","author":"Soto-Blanco","year":"2002","journal-title":"Food Chem Toxicol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib138","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1023\/B:BEBM.0000010943.77392.5c","article-title":"Demyelination of nerve fibers in the central nervous system caused by chronic exposure to natural hydrogen sulfide-containing gas","volume":"136","author":"Solnyshkova","year":"2003","journal-title":"Bull Exp Biol Med"},{"issue":"26","key":"10.1016\/j.neurot.2025.e00584_bib139","doi-asserted-by":"crossref","first-page":"8940","DOI":"10.1523\/JNEUROSCI.0026-12.2012","article-title":"Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing","volume":"32","author":"Hall","year":"2012","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00584_bib140","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1248\/bpb.b13-00502","article-title":"Assessment of effects of chronic hydrogen sulfide poisoning on cytochrome P450 isoforms activity of rats by cocktail approach","volume":"36","author":"Wang","year":"2013","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.neurot.2025.e00584_bib141","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/B978-0-444-62627-1.00008-1","article-title":"Hydrogen sulfide intoxication","volume":"131","author":"Guidotti","year":"2015","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib142","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/toxsci\/kfad022","article-title":"Investigations into hydrogen sulfide-induced suppression of neuronal activity in vivo and calcium dysregulation in vitro","volume":"192","author":"Kim","year":"2023","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib143","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44807-y","article-title":"Disrupted brain mitochondrial morphology after in vivo hydrogen sulfide exposure","volume":"13","author":"Rumbeiha","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2025.e00584_bib144","series-title":"Toxicology of cyanides and cyanogens: experimental, Applied and Clinical Aspects","year":"2015"},{"issue":"1-3","key":"10.1016\/j.neurot.2025.e00584_bib145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/ars.2023.0352","article-title":"Emerging chemical biology of protein persulfidation","volume":"39","author":"Vignane","year":"2023","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.neurot.2025.e00584_bib146","article-title":"Protein thiol alterations drive aberrant phase separation in aging","author":"Vignane","year":"2023","journal-title":"bioRxiv"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00584_bib147","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/cdd.2012.74","article-title":"PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress","volume":"19","author":"Verfaillie","year":"2012","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neurot.2025.e00584_bib148","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/B978-0-12-407704-1.00005-1","article-title":"Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration","volume":"301","author":"Bravo","year":"2013","journal-title":"Int Rev Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib149","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tibs.2015.01.002","article-title":"UPR, autophagy, and mitochondria crosstalk underlies the ER stress response","volume":"40","author":"Senft","year":"2015","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib150","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/j.2040-4603.2017.tb00748.x","article-title":"Calcium transport and signaling in mitochondria","volume":"7","author":"Bravo-Sagua","year":"2017","journal-title":"Compr Physiol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00584_bib151","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.bbamcr.2014.03.022","article-title":"Calcium trafficking integrates endoplasmic reticulum function with mitochondrial bioenergetics","volume":"1843","author":"Kaufman","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib152","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10571-016-0369-9","article-title":"Upregulation of 3-MST relates to neuronal autophagy after traumatic brain injury in mice","volume":"37","author":"Zhang","year":"2017","journal-title":"Cell Mol Neurobiol"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00584_bib153","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3390\/biom10121692","article-title":"Role of hydrogen sulfide and 3-mercaptopyruvate sulfurtransferase in the regulation of the endoplasmic reticulum stress response in hepatocytes","volume":"10","author":"Panagaki","year":"2020","journal-title":"Biomolecules"},{"issue":"17","key":"10.1016\/j.neurot.2025.e00584_bib154","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1080\/15384101.2020.1804179","article-title":"NaSH increases SIRT1 activity and autophagy flux through sulfhydration to protect SH-SY5Y cells induced by MPP","volume":"19","author":"Li","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neurot.2025.e00584_bib155","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3389\/fphar.2020.00702","article-title":"Hydrogen sulfide and endoplasmic reticulum stress: a potential therapeutic target for central nervous system degeneration diseases","volume":"11","author":"Zhong","year":"2020","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00584_bib156","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/15384101.2022.2040932","article-title":"Improvement of autophagic flux mediates the protection of hydrogen sulfide against arecoline-elicited neurotoxicity in PC12 cells","volume":"21","author":"Gao","year":"2022","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00584_bib157","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","article-title":"Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation","volume":"14","author":"Belanger","year":"2011","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00584_bib158","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/glia.20528","article-title":"Activity-dependent regulation of energy metabolism by astrocytes: an update","volume":"55","author":"Pellerin","year":"2007","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib159","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuron.2015.03.035","article-title":"A cellular perspective on brain energy metabolism and functional imaging","volume":"86","author":"Magistretti","year":"2015","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00584_bib160","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1083\/jcb.201803152","article-title":"Fueling thought: management of glycolysis and oxidative phosphorylation in neuronal metabolism","volume":"217","author":"Yellen","year":"2018","journal-title":"J Cell Biol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00584_bib161","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.neurobiolaging.2009.06.001","article-title":"Astrocytes produce the anti-inflammatory and neuroprotective agent hydrogen sulfide","volume":"30","author":"Lee","year":"2009","journal-title":"Neurobiol Aging"},{"issue":"21","key":"10.1016\/j.neurot.2025.e00584_bib162","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1158\/0008-5472.CAN-16-3480","article-title":"Upregulation of cystathionine-\u03b2-synthase in colonic epithelia reprograms metabolism and promotes carcinogenesis","volume":"77","author":"Phillips","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.neurot.2025.e00584_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102505","article-title":"Cystathionine \u03b2-synthase overexpression drives metastatic dissemination in pancreatic ductal adenocarcinoma via inducing epithelial-to-mesenchymal transformation of cancer cells","volume":"57","author":"Czikora","year":"2022","journal-title":"Redox Biol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib164","first-page":"550","article-title":"The gene for cystathionine beta-synthase (CBS) maps to the subtelomeric region on human chromosome 21q and to proximal mouse chromosome 17","volume":"42","author":"M\u00fcnke","year":"1988","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib165","doi-asserted-by":"crossref","DOI":"10.1042\/NS20200011","article-title":"Signaling pathways contributing to learning and memory deficits in the Ts65Dn mouse model of Down syndrome","volume":"5","author":"Freeburn","year":"2021","journal-title":"Neuronal Signal"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib166","first-page":"207","article-title":"The genetic background and application of Down syndrome mouse models","volume":"40","author":"Meng","year":"2018","journal-title":"Yi Chuan"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib167","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/bbrc.1998.9079","article-title":"Spatial and temporal expression of the cystathionine beta-synthase gene during early human development","volume":"254","author":"Qu\u00e9r\u00e9","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00584_bib168","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/01.RES.0000041408.64867.1D","article-title":"Structure of cerebral arterioles in cystathionine beta-synthase-deficient mice","volume":"91","author":"Baumbach","year":"2002","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib169","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/002215540305100311","article-title":"Expression of the cystathionine beta-synthase (CBS) gene during mouse development and immunolocalization in adult brain","volume":"51","author":"Robert","year":"2003","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1471-4159.2003.02297.x","article-title":"The neuronal SAPK\/JNK pathway is altered in a murine model of hyperhomocysteinemia","volume":"89","author":"Robert","year":"2004","journal-title":"J Neurochem"},{"issue":"50","key":"10.1016\/j.neurot.2025.e00584_bib171","doi-asserted-by":"crossref","first-page":"52082","DOI":"10.1074\/jbc.C400481200","article-title":"Production of the neuromodulator H2S by cystathionine beta-synthase via the condensation of cysteine and homocysteine","volume":"279","author":"Chen","year":"2004","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib172","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbrc.2004.12.028","article-title":"Hydrogen sulfide may improve the hippocampal damage induced by recurrent febrile seizures in rats","volume":"327","author":"Han","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00584_bib173","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1096\/fj.05-3724fje","article-title":"Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia\/astrocyte lineage of developing mouse CNS","volume":"19","author":"Enokido","year":"2005","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib174","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/ars.2008.2253","article-title":"3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain","volume":"11","author":"Shibuya","year":"2009","journal-title":"Antioxidants Redox Signal"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib175","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1152\/jn.00463.2011","article-title":"Hydrogen sulfide augments synaptic neurotransmission in the nucleus of the solitary tract","volume":"106","author":"Austgen","year":"2011","journal-title":"J Neurophysiol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib176","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12031-012-9948-5","article-title":"The expression changes of cystathionine-beta-synthase in brain cortex after traumatic brain injury","volume":"51","author":"Zhang","year":"2013","journal-title":"J Mol Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib177","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s11064-013-0969-4","article-title":"Dynamic change of hydrogen sulfide after traumatic brain injury and its effect in mice","volume":"38","author":"Zhang","year":"2013","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neurot.2025.e00584_bib178","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuroscience.2012.12.057","article-title":"L-Cysteine promotes the proliferation and differentiation of neural stem cells via the CBS\/H2S pathway","volume":"237","author":"Wang","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurot.2025.e00584_bib179","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neulet.2014.01.049","article-title":"Hippocampal cystathionine beta-synthase in young and aged mice","volume":"563","author":"Bruintjes","year":"2014","journal-title":"Neurosci Lett"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00584_bib180","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.molcel.2014.10.019","article-title":"Cytokine-induced GAPDH sulfhydration affects PSD95 degradation and memory","volume":"56","author":"Mir","year":"2014","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib181","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/revneuro-2014-0051","article-title":"Neuroprotective effects of hydrogen sulfide and the underlying signaling pathways","volume":"26","author":"Chen","year":"2015","journal-title":"Rev Neurosci"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00584_bib182","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1248\/bpb.b16-00334","article-title":"Reduced production of hydrogen sulfide and sulfane sulfur due to low cystathionine beta-synthase levels in brain astrocytes of stroke-prone spontaneously hypertensive rats","volume":"39","author":"Juman","year":"2016","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.neurot.2025.e00584_bib183","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2017.07.019","article-title":"Neuroprotective effects of lentivirus-mediated cystathionine-beta-synthase overexpression against 6-OHDA-induced Parkinson's disease in rats","volume":"657","author":"Yin","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurot.2025.e00584_bib184","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bbi.2017.07.156","article-title":"The cystathionine beta-synthase\/hydrogen sulfide pathway contributes to microglia-mediated neuroinflammation following cerebral ischemia","volume":"66","author":"Zhang","year":"2017","journal-title":"Brain Behav Immun"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00584_bib185","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.3390\/ijms21072520","article-title":"The Cbs locus affects the expression of senescence markers and mtDNA copy number, but not telomere dynamics, in mice","volume":"21","author":"Utyro","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib186","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/svn-2020-000584","article-title":"H2S promotes developmental brain angiogenesis via the NOS\/NO pathway in zebrafish","volume":"6","author":"Jiang","year":"2021","journal-title":"Stroke Vasc Neurol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00584_bib187","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/jimd.12661","article-title":"Homocysteine metabolites inhibit autophagy, elevate amyloid beta, and induce neuropathy by impairing Phf8\/H4K20me1-dependent epigenetic regulation of mTOR in cystathionine beta-synthase-deficient mice","volume":"46","author":"Witucki","year":"2023","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib188","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029056","article-title":"Brain phenotype of transgenic mice overexpressing cystathionine \u03b2-synthase","volume":"7","author":"R\u00e9gnier","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00584_bib189","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.RES.0000129182.46440.4a","article-title":"Modulation of cystathionine beta-synthase level regulates total serum homocysteine in mice","volume":"94","author":"Wang","year":"2004","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib190","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10519-006-9046-y","article-title":"The production of transgenic mice expressing human cystathionine beta-synthase to study Down syndrome","volume":"36","author":"Butler","year":"2006","journal-title":"Behav Genet"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00584_bib191","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1007\/s12035-018-1323-2","article-title":"Alterations in the serotonin and dopamine pathways by cystathionine beta-synthase overexpression in murine brain","volume":"56","author":"London","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00584_bib192","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1073\/pnas.0500802102","article-title":"Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes","volume":"102","author":"Vac\u00edk","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"10.1016\/j.neurot.2025.e00584_bib193","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1093\/hmg\/ddp438","article-title":"A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of Down syndrome","volume":"18","author":"Pereira","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00584_bib194","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1073\/pnas.92.5.1585","article-title":"Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia","volume":"92","author":"Watanabe","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"10.1016\/j.neurot.2025.e00584_bib195","doi-asserted-by":"crossref","first-page":"7905","DOI":"10.3390\/molecules27227905","article-title":"Methylglyoxal in the brain: from glycolytic metabolite to signaling molecule","volume":"27","author":"Yang","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib196","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12987-023-00477-6","article-title":"Methylglyoxal, a highly reactive dicarbonyl compound, as a threat for blood-brain barrier integrity","volume":"20","author":"Berends","year":"2023","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib197","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12672-022-00521-1","article-title":"Acetyl-CoA synthetase 2 (ACSS2): a review with a focus on metabolism and tumor development","volume":"13","author":"Ling","year":"2022","journal-title":"Discov Oncol"},{"key":"10.1016\/j.neurot.2025.e00584_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115741","article-title":"Acetyl-CoA metabolism as a therapeutic target for cancer","volume":"168","author":"Chen","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188837","article-title":"Acetyl-CoA regulates lipid metabolism and histone acetylation modification in cancer","volume":"1878","author":"He","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.neurot.2025.e00584_bib200","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2010.09.107","article-title":"Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice","volume":"1366","author":"Yu","year":"2010","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib201","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0022-510X(90)90182-M","article-title":"Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer disease","volume":"98","author":"J\u00f8rgensen","year":"1990","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurot.2025.e00584_bib202","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainresbull.2017.02.001","article-title":"Human astrocytes in the diseased brain","volume":"136","author":"Dossi","year":"2018","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neurot.2025.e00584_bib203","article-title":"Reactive astrogliosis in the era of single-cell transcriptomics","volume":"17","author":"Matusova","year":"2023","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.neurot.2025.e00584_bib204","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-031-64839-7_10","article-title":"Astrocyte regulation of neuronal function and survival in stroke pathophysiology","volume":"39","author":"Boyle","year":"2024","journal-title":"Adv Neurobiol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib205","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41392-023-01628-9","article-title":"Astrocytes in human central nervous system diseases: a frontier for new therapies","volume":"8","author":"Verkhratsky","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.neurot.2025.e00584_bib206","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12264-024-01258-3","article-title":"From physiology to pathology of astrocytes: highlighting their potential as therapeutic targets for CNS injury","volume":"41","author":"Yuan","year":"2025","journal-title":"Neurosci Bull"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00584_bib207","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/hmg\/ddq179","article-title":"A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions","volume":"19","author":"Yu","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib208","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/hmg\/ddt446","article-title":"Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits","volume":"23","author":"Zhang","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00584_bib209","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134861","article-title":"Down syndrome cognitive phenotypes modeled in mice trisomic for all HSA 21 homologues","volume":"10","author":"Belichenko","year":"2015","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.neurot.2025.e00584_bib210","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1093\/hmg\/ddv364","article-title":"Genetic dissection of the Down syndrome critical region","volume":"24","author":"Jiang","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00584_bib211","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/hmg\/ddad056","article-title":"Dissection of a Down syndrome-associated trisomy to separate the gene dosage-dependent and -independent effects of an extra chromosome","volume":"32","author":"Xing","year":"2023","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib212","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbr.2009.08.034","article-title":"Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1)","volume":"206","author":"Costa","year":"2010","journal-title":"Behav Brain Res"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00584_bib213","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049721","article-title":"Ts66Yah, a mouse model of Down syndrome with improved construct and face validity","volume":"15","author":"Duchon","year":"2022","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.neurot.2025.e00584_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106523","article-title":"Shaping Down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model","volume":"196","author":"Lanzillotta","year":"2024","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib215","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11248-013-9772-x","article-title":"A novel mouse model for Down syndrome that harbor a single copy of human artificial chromosome (HAC) carrying a limited number of genes from human chromosome 21","volume":"23","author":"Miyamoto","year":"2014","journal-title":"Transgenic Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib216","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ajhg.2021.12.015","article-title":"A transchromosomic rat model with human chromosome 21 shows robust Down syndrome features","volume":"109","author":"Kazuki","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00584_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108379","article-title":"Neocortical neuronal production and maturation defects in the TcMAC21 mouse model of Down syndrome","volume":"26","author":"Kurabayashi","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.neurot.2025.e00584_bib218","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115302","article-title":"Dosage of the Abcg1-U2af1 region modifies locomotor and cognitive deficits observed in the Tc1 mouse model of Down syndrome","volume":"10","author":"Marechal","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00584_bib219","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00001756-200004070-00044","article-title":"Polymorphisms of genes controlling homocysteine\/folate metabolism and cognitive function","volume":"11","author":"Barbaux","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurot.2025.e00584_bib220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1744-9081-1-25","article-title":"Cystathionine beta-synthase T833C\/844INS68 polymorphism a family-based study on mentally retarded children","volume":"1","author":"Dutta","year":"2005","journal-title":"Behav Brain Funct"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib221","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neulet.2009.02.040","article-title":"Correlation between cystathionine beta synthase gene polymorphisms plasma homocysteine and idiopathic mental retardation in Indian individuals from Kolkata","volume":"453","author":"Dutta","year":"2009","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib222","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3233\/JAD-170162","article-title":"Increased plasma homocysteine level is associated with executive dysfunction in Type 2 diabetic patients with mild cognitive impairment","volume":"58","author":"Tian","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib223","first-page":"325","article-title":"Identification of three novel pathogenic mutations in cystathionine beta-synthase gene of Pakistani intellectually disabled patients","volume":"35","author":"Wasim","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib224","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00415-022-11361-y","article-title":"Homocysteine levels genetic background and cognitive impairment in Parkinson's disease","volume":"270","author":"Peri\u00f1\u00e1n","year":"2023","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib225","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/bph.15991","article-title":"Recent therapeutic approaches to cystathionine beta-synthase-deficient homocystinuria","volume":"180","author":"Majtan","year":"2023","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib226","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/jpm14020156","article-title":"The impact of genetics on cognition insights into cognitive disorders and single nucleotide polymorphisms","volume":"14","author":"Spoto","year":"2024","journal-title":"J Personalized Med"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00584_bib227","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1515\/CCLM.2003.226","article-title":"Genetic determinants of folate and vitamin B12 metabolism a common pathway in neural tube defect and Down syndrome","volume":"41","author":"Gu\u00e9ant","year":"2003","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib228","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1038\/s41598-021-83379-7","article-title":"One-carbon pathway and cognitive skills in children with Down syndrome","volume":"11","author":"Antonaros","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib229","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/tera.10033","article-title":"Homocysteine modifies development of neurulation and dorsal root ganglia in chick embryos","volume":"65","author":"Epeldegui","year":"2002","journal-title":"Teratology"},{"key":"10.1016\/j.neurot.2025.e00584_bib230","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1038\/s41467-018-05451-7","article-title":"Elevated H3K79 homocysteinylation causes abnormal gene expression during neural development and subsequent neural tube defects","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurot.2025.e00584_bib231","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.biochi.2020.02.012","article-title":"Mechanisms of homocysteine-induced damage to the endothelial medial and adventitial layers of the arterial wall","volume":"173","author":"Balint","year":"2020","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib232","doi-asserted-by":"crossref","DOI":"10.1002\/dneu.22958","article-title":"Elevated serum homocysteine levels impair embryonic neurodevelopment by dysregulating the heat shock proteins","volume":"85","author":"Mai","year":"2025","journal-title":"Dev Neurobiol"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib233","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neures.2010.07.2039","article-title":"Hydrogen sulfide antagonizes homocysteine-induced neurotoxicity in PC12 cells","volume":"68","author":"Tang","year":"2010","journal-title":"Neurosci Res"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib234","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.3892\/mmr.2017.7004","article-title":"Hydrogen sulfide prevents homocysteine-induced endoplasmic reticulum stress in PC12 cells by upregulating SIRT-1","volume":"16","author":"Wang","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.neurot.2025.e00584_bib235","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neuint.2018.07.010","article-title":"Hydrogen sulfide attenuates homocysteine-induced neurotoxicity by preventing mitochondrial dysfunctions and oxidative damage in vitro and in vivo studies","volume":"120","author":"Kumar","year":"2018","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neurot.2025.e00584_bib236","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7629673","article-title":"Imbalance of homocysteine and H2S significance, mechanisms and therapeutic promise in vascular injury","volume":"2019","author":"Yang","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.neurot.2025.e00584_bib237","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.mito.2019.11.004","article-title":"Hydrogen sulfide attenuates hyperhomocysteinemia-induced mitochondrial dysfunctions in brain","volume":"50","author":"Kumar","year":"2020","journal-title":"Mitochondrion"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00584_bib238","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/00207454.2020.1860967","article-title":"Hydrogen sulfide attenuates hyperhomocysteinemia-induced blood-brain barrier permeability by inhibiting MMP-9","volume":"132","author":"Kumar","year":"2022","journal-title":"Int J Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib239","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jphs.2024.05.001","article-title":"H2S prevents the disruption of the blood-brain barrier in rats with prenatal hyperhomocysteinemia","volume":"155","author":"Yakovlev","year":"2024","journal-title":"J Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib240","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ana.24372","article-title":"Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis","volume":"77","author":"Davoli","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurot.2025.e00584_bib241","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bcp.2017.11.019","article-title":"Gasotransmitter hydrogen sulfide signaling in neuronal health and disease","volume":"149","author":"Paul","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00584_bib242","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910695","article-title":"Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology","volume":"11","author":"Ide","year":"2019","journal-title":"EMBO Mol Med"},{"issue":"Suppl 3","key":"10.1016\/j.neurot.2025.e00584_bib243","doi-asserted-by":"crossref","first-page":"S443","DOI":"10.1007\/s10545-010-9227-y","article-title":"Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy","volume":"33","author":"Barth","year":"2010","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib244","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/ars.2010.3520","article-title":"Chronic exposure to sulfide causes accelerated degradation of cytochrome c oxidase in ethylmalonic encephalopathy","volume":"15","author":"Di Meo","year":"2011","journal-title":"Antioxidants Redox Signal"},{"issue":"53","key":"10.1016\/j.neurot.2025.e00584_bib245","doi-asserted-by":"crossref","first-page":"44561","DOI":"10.1074\/jbc.M112.407411","article-title":"Characterization of patient mutations in human persulfide dioxygenase (ETHE1) involved in H2S catabolism","volume":"287","author":"Kabil","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurot.2025.e00584_bib246","article-title":"Ethylmalonic encephalopathy Clinical course and therapy response in an uncommon mild case with a severe ETHE1 mutation","volume":"25","author":"Ersoy","year":"2020","journal-title":"Mol Genet Metab Rep"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00584_bib247","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1007\/s10072-023-06904-8","article-title":"Ethylmalonic Encephalopathy a literature review and two new cases of mild phenotype","volume":"44","author":"Platt","year":"2023","journal-title":"Neurol Sci"},{"issue":"15","key":"10.1016\/j.neurot.2025.e00584_bib248","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170994","article-title":"Exclusion of sulfide:quinone oxidoreductase from mitochondria causes Leigh-like disease in mice by impairing sulfide metabolism","volume":"134","author":"Kanemaru","year":"2024","journal-title":"J Clin Investig"},{"key":"10.1016\/j.neurot.2025.e00584_bib249","article-title":"Essential role of sulfide oxidation in brain health and neurological disorders","volume":"266","author":"Kanemaru","year":"2024","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neurot.2025.e00584_bib250","first-page":"41","article-title":"The Down syndrome critical region","volume":"57","author":"Shapiro","year":"1999","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.neurot.2025.e00584_bib251","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.770359","article-title":"Structural characterization of the highly restricted Down syndrome critical region on 21q22.13: new KCNJ6 and DSCR4 transcript isoforms","volume":"12","author":"Antonaros","year":"2021","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib252","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12920-022-01422-6","article-title":"Partial trisomy 21 with or without highly restricted Down syndrome critical region (HR-DSCR): report of two new cases and reanalysis of the genotype-phenotype association","volume":"15","author":"Pelleri","year":"2022","journal-title":"BMC Med Genom"},{"issue":"Pt 11","key":"10.1016\/j.neurot.2025.e00584_bib253","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1242\/jcs.000703","article-title":"The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and Citron kinase","volume":"120","author":"Berto","year":"2007","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neurot.2025.e00584_bib254","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2024.11.043","article-title":"Altered mitochondrial unfolded protein response and protein quality control promote oxidative distress in down syndrome brain","volume":"227","author":"Lanzillotta","year":"2024","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib255","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3934\/Neuroscience.2021015","article-title":"From the lab to the people: major challenges in the biological treatment of Down syndrome","volume":"8","author":"Rondal","year":"2021","journal-title":"AIMS Neurosci"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00584_bib256","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00439-024-02651-8","article-title":"Trisomy silencing by XIST: translational prospects and challenges","volume":"143","author":"Gupta","year":"2024","journal-title":"Hum Genet"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00584_bib257","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00018-022-04479-9","article-title":"H2S biogenesis by cystathionine beta-synthase: mechanism of inhibition by aminooxyacetic acid and unexpected role of serine","volume":"79","author":"Petrosino","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00584_bib258","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.brainresbull.2012.02.003","article-title":"Therapeutic effect of Yokukansan on social isolation-induced aggressive behavior of zinc-deficient and pair-fed mice","volume":"87","author":"Takeda","year":"2012","journal-title":"Brain Res Bull"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib259","doi-asserted-by":"crossref","first-page":"451","DOI":"10.31083\/j.jin.2019.04.1119","article-title":"Effects of aminooxyacetic acid on hippocampal mitochondria in rats with chronic alcoholism: the analysis of learning and memory-related genes","volume":"18","author":"Du","year":"2019","journal-title":"J Integr Neurosci"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00584_bib260","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.4103\/1673-5374.237120","article-title":"Aminooxyacetic acid improves learning and memory in a rat model of chronic alcoholism","volume":"13","author":"Du","year":"2018","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.neurot.2025.e00584_bib261","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2119\/molmed.2016.00102","article-title":"Cystathionine-beta-synthase inhibition for colon cancer: enhancement of the efficacy of aminooxyacetic acid via the prodrug approach","volume":"22","author":"Chao","year":"2016","journal-title":"Mol Med"},{"key":"10.1016\/j.neurot.2025.e00584_bib262","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.neubiorev.2016.10.023","article-title":"Plant polyphenols as natural drugs for the management of Down syndrome and related disorders","volume":"71","author":"Vacca","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00584_bib263","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/brainsci8100187","article-title":"DYRK1A protein, a promising therapeutic target to improve cognitive deficits in Down syndrome","volume":"8","author":"Feki","year":"2018","journal-title":"Brain Sci"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00584_bib264","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1474-4422(16)30034-5","article-title":"Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"15","author":"de la Torre","year":"2016","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib265","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(21)00369-0","article-title":"Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial","volume":"21","author":"Costa","year":"2022","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00584_bib266","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.gim.2022.06.011","article-title":"Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study)","volume":"24","author":"Cieuta-Walti","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.neurot.2025.e00584_bib267","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2021.110186","article-title":"Opportunities and challenges for the nanodelivery of green tea catechins in functional foods","volume":"142","author":"Rashidinejad","year":"2021","journal-title":"Food Res Int"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00584_bib268","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14189","article-title":"Epigallocatechin gallate: phytochemistry, bioavailability, utilization challenges, and strategies","volume":"46","author":"Mehmood","year":"2022","journal-title":"J Food Biochem"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00584_bib269","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","article-title":"Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications","volume":"82","author":"Singh","year":"2011","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00584_bib270","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/molecules23061295","article-title":"In vitro and in silico studies of the molecular interactions of epigallocatechin-3-O-gallate (EGCG) with proteins that explain the health benefits of green tea","volume":"23","author":"Saeki","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib271","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/molecules25030467","article-title":"Preclinical pharmacological activities of epigallocatechin-3-gallate in signaling pathways: an opdate on cancer","volume":"25","author":"Sharifi-Rad","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib272","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s43556-024-00240-9","article-title":"Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies","volume":"5","author":"Alam","year":"2024","journal-title":"Mol Biomed"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib273","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1080\/13880209.2024.2406779","article-title":"Epigallocatechin-3-gallate at the nanoscale: a new strategy for cancer treatment","volume":"62","author":"Sun","year":"2024","journal-title":"Pharm Biol"},{"issue":"Pt A","key":"10.1016\/j.neurot.2025.e00584_bib274","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2016.08.016","volume":"113","author":"Druzhyna","year":"2016","journal-title":"Pharmacol Res"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00584_bib275","first-page":"2409","article-title":"The effect of levodopa benserazide hydrochloride on homocysteinemia levels in patients with Parkinson's disease and treatment of hyperhomocysteinemia","volume":"20","author":"Guo","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.neurot.2025.e00584_bib276","article-title":"Benserazide, a cystathionine beta-synthase (CBS) inhibitor, potentially enhances the anticancer effects of paclitaxel via inhibiting the S-sulfhydration of SIRT1 and the HIF1-alpha\/VEGF pathway","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib277","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.amjmed.2016.10.004","article-title":"Treatment of alcohol use disorder in patients with alcoholic liver disease","volume":"130","author":"Leggio","year":"2017","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib278","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/antibiotics12030524","article-title":"Disulfiram: mechanisms, applications, and challenges","volume":"12","author":"Lanz","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00584_bib279","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/CM9.0000000000002909","article-title":"Disulfiram: a novel repurposed drug for cancer therapy","volume":"137","author":"Zeng","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.neurot.2025.e00584_bib280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114267","article-title":"Mechanism of cystathionine-\u03b2-synthase inhibition by disulfiram: the role of bis(N,N-diethyldithiocarbamate)-copper(II)","volume":"182","author":"Zuhra","year":"2020","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00584_bib281","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/pr.117.014050","article-title":"International union of basic and clinical pharmacology. CII: pharmacological modulation of H2S levels: H2S donors and H2S biosynthesis inhibitors","volume":"69","author":"Szabo","year":"2017","journal-title":"Pharmacol Rev"},{"issue":"s1","key":"10.1016\/j.neurot.2025.e00584_bib282","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.3233\/JAD-240078","article-title":"Leucettinib-21, a DYRK1A kinase inhibitor as clinical drug candidate for Alzheimer's disease and Down syndrome","volume":"101","author":"Meijer","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurot.2025.e00584_bib283","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.1110163","article-title":"New insights into the regulation of cystathionine beta synthase (CBS), an enzyme involved in intellectual deficiency in Down syndrome","volume":"16","author":"Conan","year":"2023","journal-title":"Front Neurosci"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00584_bib284","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3390\/ph17081090","article-title":"Network pharmacology identifies intersection genes of apigenin and naringenin in Down syndrome as potential therapeutic targets","volume":"17","author":"Amir","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00584_bib285","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3390\/biom11081073","article-title":"Efficacy of novel aminooxyacetic acid prodrugs in colon cancer models: towards clinical translation of the cystathionine \u03b2-synthase inhibition concept","volume":"11","author":"Hellmich","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib286","first-page":"428","article-title":"Toward the identification of neurophysiological biomarkers for Alzheimer's Disease in Down syndrome: a potential role for cross-frequency phase-amplitude coupling analysis","volume":"14","author":"Victorino","year":"2023","journal-title":"Aging Dis"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib287","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/brainsci14020136","article-title":"EEG in Down syndrome-a review and insights into potential neural mechanisms","volume":"14","author":"Chmiel","year":"2024","journal-title":"Brain Sci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00584_bib288","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14187","article-title":"Comparison of power spectra from overnight electroencephalography between patients with Down syndrome and matched control subjects","volume":"33","author":"Talukder","year":"2024","journal-title":"J Sleep Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib289","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s11689-022-09418-0","article-title":"A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABA(A)-alpha 5 NAM (basmisanil) on intellectual disability associated with Down syndrome","volume":"14","author":"Goeldner","year":"2022","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.neurot.2025.e00584_bib290","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13293-015-0043-9","article-title":"Sex differences in protein expression in the mouse brain and their perturbations in a model of Down syndrome","volume":"6","author":"Block","year":"2015","journal-title":"Biol Sex Differ"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib291","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.niox.2010.11.001","article-title":"Cardioprotective effects of hydrogen sulfide","volume":"25","author":"Szab\u00f3","year":"2011","journal-title":"Nitric Oxide"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00584_bib292","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.tips.2015.05.007","article-title":"The role of H2S bioavailability in endothelial dysfunction","volume":"36","author":"Wang","year":"2015","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00584_bib293","doi-asserted-by":"crossref","first-page":"C537","DOI":"10.1152\/ajpcell.00329.2016","article-title":"Vascular biology of hydrogen sulfide","volume":"312","author":"Kanagy","year":"2017","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00584_bib294","doi-asserted-by":"crossref","first-page":"C3","DOI":"10.1152\/ajpcell.00282.2016","article-title":"Hydrogen sulfide, an enhancer of vascular nitric oxide signaling: mechanisms and implications","volume":"312","author":"Szabo","year":"2017","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00584_bib295","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/CIRCRESAHA.118.311134","article-title":"Evolution of hydrogen sulfide therapeutics to treat cardiovascular disease","volume":"123","author":"Li","year":"2018","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00584_bib296","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3390\/biom14091145","article-title":"Hydrogen sulfide: a versatile molecule and therapeutic target in Health and Diseases","volume":"14","author":"Shahid","year":"2024","journal-title":"Biomolecules"},{"issue":"6081","key":"10.1016\/j.neurot.2025.e00584_bib297","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/bmj.2.6081.226","article-title":"Down's syndrome: an atheroma-free model?","volume":"2","author":"Murdoch","year":"1977","journal-title":"Br Med J"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00584_bib298","first-page":"1283","article-title":"Down syndrome: a cardiovascular perspective","volume":"54","author":"Vis","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00584_bib299","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/MOP.0000000000000661","article-title":"Cardiovascular disease in Down syndrome","volume":"30","author":"Versacci","year":"2018","journal-title":"Curr Opin Pediatr"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00584_bib300","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/jch.13930","article-title":"Adults with Down syndrome challenge another paradigm: when aging no longer entails arterial hypertension","volume":"22","author":"Roy-Vallejo","year":"2020","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.neurot.2025.e00584_bib301","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.122.059706","article-title":"Cardiovascular complications of Down syndrome: scoping review and expert consensus","volume":"147","author":"Dimopoulos","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00584_bib302","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd.2015.1","article-title":"Gasotransmitters in cancer: from pathophysiology to experimental therapy","volume":"15","author":"Szabo","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neurot.2025.e00584_bib303","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3205125","article-title":"Cystathionine beta-synthase in physiology and cancer","volume":"2018","author":"Zhu","year":"2018","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.neurot.2025.e00584_bib304","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2018.11.034","article-title":"Potential role of the 3-mercaptopyruvate sulfurtransferase (3-MST)-hydrogen sulfide (H2S) pathway in cancer cells","volume":"154","author":"Augsburger","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.neurot.2025.e00584_bib305","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102331","article-title":"Emerging roles of cystathionine beta-synthase in various forms of cancer","volume":"53","author":"Ascen\u00e7\u00e3o","year":"2022","journal-title":"Redox Biol"},{"key":"10.1016\/j.neurot.2025.e00584_bib306","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111226","article-title":"Emerging roles of hydrogen sulfide in colorectal cancer","volume":"403","author":"Jiang","year":"2024","journal-title":"Chem Biol Interact"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00584_bib307","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ajmg.1320140206","article-title":"Down syndrome--a disruption of homeostasis","volume":"14","author":"Shapiro","year":"1983","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.neurot.2025.e00584_bib308","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.749480","article-title":"Ten reasons why people with Down syndrome are protected from the development of most solid tumors - a review","volume":"12","author":"Osuna-Marco","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.neurot.2025.e00584_bib309","doi-asserted-by":"crossref","DOI":"10.1177\/20406207241257901","article-title":"Down syndrome-associated leukaemias: current evidence and challenges","volume":"15","author":"Mason","year":"2024","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.neurot.2025.e00584_bib310","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104558","article-title":"The prevalence of solid tumors and hematologic malignancies among patients with Down syndrome: a systematic review and meta-analysis","volume":"205","author":"Moretti","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.neurot.2025.e00584_bib311","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102595","article-title":"Effects of methionine intake on cognitive function in mild cognitive impairment patients and APP\/PS1 Alzheimer's Disease model mice: role of the cystathionine-beta-synthase\/H2S pathway","volume":"59","author":"Xi","year":"2023","journal-title":"Redox Biol"},{"key":"10.1016\/j.neurot.2025.e00584_bib312","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2014.01.004","article-title":"Hydrogen sulfide improves spatial memory impairment and decreases production of A\u03b2 in APP\/PS1 transgenic mice","volume":"67","author":"He","year":"2014","journal-title":"Neurochem Int"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:29:02Z","timestamp":1763771342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925000625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":312,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1878747925000625"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00584","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of cystathionine-\u03b2-synthase and hydrogen sulfide in down syndrome","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00584"}}